272 related articles for article (PubMed ID: 26910894)
21. BRAF, KRAS and PIK3CA mutations in colorectal serrated polyps and cancer: primary or secondary genetic events in colorectal carcinogenesis?
Velho S; Moutinho C; Cirnes L; Albuquerque C; Hamelin R; Schmitt F; Carneiro F; Oliveira C; Seruca R
BMC Cancer; 2008 Sep; 8():255. PubMed ID: 18782444
[TBL] [Abstract][Full Text] [Related]
22. Distinct WNT/β-catenin signaling activation in the serrated neoplasia pathway and the adenoma-carcinoma sequence of the colorectum.
Murakami T; Mitomi H; Saito T; Takahashi M; Sakamoto N; Fukui N; Yao T; Watanabe S
Mod Pathol; 2015 Jan; 28(1):146-58. PubMed ID: 24925057
[TBL] [Abstract][Full Text] [Related]
23. BRAF and KRAS mutations in colorectal hyperplastic polyps and serrated adenomas.
Chan TL; Zhao W; Leung SY; Yuen ST;
Cancer Res; 2003 Aug; 63(16):4878-81. PubMed ID: 12941809
[TBL] [Abstract][Full Text] [Related]
24. Serrated colorectal polyps in inflammatory bowel disease.
Ko HM; Harpaz N; McBride RB; Cui M; Ye F; Zhang D; Ullman TA; Polydorides AD
Mod Pathol; 2015 Dec; 28(12):1584-93. PubMed ID: 26403785
[TBL] [Abstract][Full Text] [Related]
25. Traditional serrated adenoma-like lesions in patients with inflammatory bowel disease.
Miller GC; Liu C; Bettington ML; Leggett B; Whitehall VLJ; Rosty C
Hum Pathol; 2020 Mar; 97():19-28. PubMed ID: 31917154
[TBL] [Abstract][Full Text] [Related]
26. Molecular and histologic considerations in the assessment of serrated polyps.
Yang HM; Mitchell JM; Sepulveda JL; Sepulveda AR
Arch Pathol Lab Med; 2015 Jun; 139(6):730-41. PubMed ID: 26030242
[TBL] [Abstract][Full Text] [Related]
27. Hyperplastic polyps of the colon and rectum - reclassification, BRAF and KRAS status in index polyps and subsequent colorectal carcinoma.
Janjua HG; Høgdall E; Linnemann D
APMIS; 2015 Apr; 123(4):298-304. PubMed ID: 25708741
[TBL] [Abstract][Full Text] [Related]
28. Serrated Lesions in Inflammatory Bowel Disease: Genotype-Phenotype Correlation.
Brcic I; Dawson H; Gröchenig HP; Högenauer C; Kashofer K
Int J Surg Pathol; 2021 Feb; 29(1):46-53. PubMed ID: 33030071
[TBL] [Abstract][Full Text] [Related]
29. Advanced colorectal polyps with the molecular and morphological features of serrated polyps and adenomas: concept of a 'fusion' pathway to colorectal cancer.
Jass JR; Baker K; Zlobec I; Higuchi T; Barker M; Buchanan D; Young J
Histopathology; 2006 Aug; 49(2):121-31. PubMed ID: 16879389
[TBL] [Abstract][Full Text] [Related]
30. Reappraisal of the genetic heterogeneity of sessile serrated adenoma/polyp.
Cho H; Hashimoto T; Yoshida H; Taniguchi H; Ogawa R; Mori T; Hiraoka N; Saito Y; Sekine S
Histopathology; 2018 Oct; 73(4):672-680. PubMed ID: 29920740
[TBL] [Abstract][Full Text] [Related]
31. Serrated and non-serrated polyps of the colorectum: their prevalence in an unselected case series and correlation of BRAF mutation analysis with the diagnosis of sessile serrated adenoma.
Carr NJ; Mahajan H; Tan KL; Hawkins NJ; Ward RL
J Clin Pathol; 2009 Jun; 62(6):516-8. PubMed ID: 19126563
[TBL] [Abstract][Full Text] [Related]
32. KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia.
Juárez M; Egoavil C; Rodríguez-Soler M; Hernández-Illán E; Guarinos C; García-Martínez A; Alenda C; Giner-Calabuig M; Murcia O; Mangas C; Payá A; Aparicio JR; Ruiz FA; Martínez J; Casellas JA; Soto JL; Zapater P; Jover R
PLoS One; 2017; 12(9):e0184937. PubMed ID: 28953955
[TBL] [Abstract][Full Text] [Related]
33. Beta-catenin nuclear labeling is a common feature of sessile serrated adenomas and correlates with early neoplastic progression after BRAF activation.
Yachida S; Mudali S; Martin SA; Montgomery EA; Iacobuzio-Donahue CA
Am J Surg Pathol; 2009 Dec; 33(12):1823-32. PubMed ID: 19745699
[TBL] [Abstract][Full Text] [Related]
34. Tracing origin of serrated adenomas with BRAF and KRAS mutations.
Lee EJ; Choi C; Park CK; Maeng L; Lee J; Lee A; Kim KM
Virchows Arch; 2005 Sep; 447(3):597-602. PubMed ID: 15991007
[TBL] [Abstract][Full Text] [Related]
35. Identification of histologically distinct conventional adenomas that arise predominately in patients with sessile serrated adenomas.
Pai RK; Mackinnon AC; Joseph L; Noffsinger A; Hart J
Am J Surg Pathol; 2010 Mar; 34(3):355-63. PubMed ID: 20118768
[TBL] [Abstract][Full Text] [Related]
36. Frequent activating GNAS mutations in villous adenoma of the colorectum.
Yamada M; Sekine S; Ogawa R; Taniguchi H; Kushima R; Tsuda H; Kanai Y
J Pathol; 2012 Sep; 228(1):113-8. PubMed ID: 22374786
[TBL] [Abstract][Full Text] [Related]
37. Over-expression of cathepsin E and trefoil factor 1 in sessile serrated adenomas of the colorectum identified by gene expression analysis.
Caruso M; Moore J; Goodall GJ; Thomas M; Phillis S; Tyskin A; Cheetham G; Lerda N; Takahashi H; Ruszkiewicz A
Virchows Arch; 2009 Mar; 454(3):291-302. PubMed ID: 19172291
[TBL] [Abstract][Full Text] [Related]
38. Endoscopic and molecular characterization of colorectal sessile serrated adenoma/polyps with cytologic dysplasia.
Tanaka Y; Yamano HO; Yamamoto E; Matushita HO; Aoki H; Yoshikawa K; Takagi R; Harada E; Nakaoka M; Yoshida Y; Eizuka M; Sugai T; Suzuki H; Nakase H
Gastrointest Endosc; 2017 Dec; 86(6):1131-1138.e4. PubMed ID: 28501592
[TBL] [Abstract][Full Text] [Related]
39. Somatic targeted mutation profiling of colorectal cancer precursor lesions.
Dos Santos W; Dos Reis MB; Porto J; de Carvalho AC; Matsushita M; Oliveira G; Syrjänen K; Reis RM; Guimarães DP
BMC Med Genomics; 2022 Jun; 15(1):143. PubMed ID: 35761395
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers for the identification of precursor polyps of colorectal serrated adenocarcinomas.
García-Solano J; García-Solano ME; Torres-Moreno D; Carbonell P; Trujillo-Santos J; Pérez-Guillermo M; Conesa-Zamora P
Cell Oncol (Dordr); 2016 Jun; 39(3):243-52. PubMed ID: 26832730
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
